FDA criticizes Ranbaxy India plant
Wednesday, February 25, 2009 - 12:42
in Mathematics & Economics
WASHINGTON, Feb. 25 (UPI) -- The U.S. Food and Drug Administration says it is taking new regulatory action against Ranbaxy Pharmaceuticals Inc.'s Paonta Sahib plant in India.